2003•PubMedRequires access

[Renal osteodystrophy and biochemical markers of bone turnover].

Senji Okuno

Abstract

Renal osteodystrophy which associates with high rates of morbidity in patients with chronic renal failure is not an uniform metabolic bone disease. Although bone histomorphometry is the most reliable diagnostic method, several biochemical markers have been proposed for evaluation of bone turnover in hemodialysis patients. This review assesses the value and the limitations of several serum markers of bone metabolism in patients with chronic renal failure.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Renal osteodystrophy, Bone remodeling, Bone histomorphometry, Medicine, Chronic renal failure, Hemodialysis, Chronic kidney disease-mineral and bone disorder, Metabolic bone disease